1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Multiple Myeloma

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manning, LS; Radin, NS1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Multiple Myeloma

ArticleYear
Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.
    British journal of cancer, 1999, Volume: 81, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Glucosyltransferases; Glycolipids; Histocompatibility Antigens Class II; Mice; Morpholines; Multiple Myeloma; Phenotype; Tumor Cells, Cultured

1999